Low-dose Decitabine Enhances Chidamide-Induced Apoptosis in Adult Acute Lymphoblast Leukemia, Especially for p16-Deleted Patients Through DNA Damage

References

• Bassan R , HoelzerD . Modern therapy of acute lymphoblastic leukemia . J. Clin. Oncol.29 ( 5 ), 532 – 543 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Jabbour E , O’BrienS , RavandiF , KantarjianH . Monoclonal antibodies in acute lymphoblastic leukemia . Blood125 ( 26 ), 4010 – 4016 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gökbuget N1 , StanzeD , BeckJet al. German multicenter study group for adult acute lymphoblastic leukemia. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation . Blood120 ( 10 ), 2032 – 2041 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Eigendorff E , HochhausA . Acute leukemia in adults . Pathologe36 ( 5 ), 503 – 517 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chan TA , BaylinSB . Epigenetic biomarkers . Curr. Top. Microbiol. Immunol.355 , 189 – 216 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Stahl M , KohrmanN , GoreSDet al. Epigenetics in cancer: a hematological perspective . PLoS Genet.12 ( 10 ), e1006193 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ganesan A , NolanL , CrabbSJ , PackhamG . Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery . Curr. Cancer Drug Targets9 ( 8 ), 963 – 981 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zahnow CA , TopperM , StoneMet al. Inhibitors of DNA methylation, histone deacetylation, and histone demethylation: a perfect combination for cancer therapy . Adv. Cancer Res.130 , 55 – 111 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bhatla T , WangJ , MorrisonDJet al. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia . Blood119 ( 22 ), 5201 – 5210 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang YZ , QiuSC . Prediction of key genes in ovarian cancer treated with decitabine based on network strategy . Oncol. Rep.35 ( 6 ), 3548 – 3558 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Welch JS , PettiAA , MillerCAet al. TP53 and decitabine in acute myeloid leukemia and Myelodysplastic syndromes . N. Engl. J. Med.375 ( 21 ), 2023 – 2036 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Park H , ChungH , LeeJet al. Decitabine as a first-line treatment for older adults newly diagnosed with acute myeloid leukemia . Yonsei Med. J.58 ( 1 ), 35 – 42 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Serravalle S , BertuccioSN , AstolfiA , MelchiondaF , PessionA . Synergistic cytotoxic effect of L-asparaginase combined with decitabine as a demethylating agent in pediatric T-ALL, with specific epigenetic signature . Biomed. Res. Int. 2016 , 1985750 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Si J , BoumberYA , ShuJet al. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation . Cancer Res.70 ( 17 ), 6968 – 6977 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cameron EE , BachmanKE , MyöhänenS , HermanJG , BaylinSB . Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer . Nat. Genet.21 ( 1 ), 103 – 107 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Grishina O , SchmoorC , DöhnerKet al. DECIDER: prospective randomized multicenter Phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy . BMC Cancer15 , 430 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kirschbaum M , GojoI , GoldbergSLet al. A Phase I clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome . Br. J. Haematol.167 ( 2 ), 185 – 193 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Burke MJ , LambaJK , PoundsSet al. A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia . Am. J. Hematol.89 ( 9 ), 889 – 895 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhao B , HeT . Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer . Oncol. Rep.33 ( 1 ), 304 – 310 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhou Y , PanDS , ShanSet al. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in non-small-cell lung cancer cells . Biomed. Pharmacother.68 ( 4 ), 483 – 491 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Liu L , QiuS , LiuYet al. Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice . Neoplasma63 ( 2 ), 193 – 200 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Li Y , ChenK , ZhouYet al. A new strategy to target acute myeloid leukemia stem and progenitor cells using chidamide, a histone deacetylase inhibitor . Curr. Cancer Drug Targets15 ( 6 ), 493 – 503 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lu X , NingZ , LiZ , CaoH , WangX . Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China . Intractable Rare Dis. Res.5 ( 3 ), 185 – 191 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Dong M , NingZQ , XingPYet al. Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas . Cancer Chemother. Pharmacol.69 ( 6 ), 1413 – 1422 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hu X , WangL , LinLet al. A Phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer . Chin. J. Cancer Res.28 ( 4 ), 444 – 451 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kang ZJ , LiuYFet al. The Philadelphia chromosome in leukemogenesis . Chin. J. Cancer.35 , 48 ( 2016 ).
   PubMedGoogle Scholar
• Wang Y , ChenG , CaoRet al. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia . Pharmacogenomics18 ( 1 ), 77 – 84 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Maes K , De SmedtE , LemaireMet al. The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma . Oncotarget.5 ( 10 ), 3115 – 3129 ( 2014 ).
   PubMedGoogle Scholar
• Liu Y , LongYH , WangSQ , LiYF , ZhangJH . Phosphorylation of H2A.XTyr39 positively regulates DNA damage response and is linked to cancer progression . FEBS J.283 ( 24 ), 4462 – 4473 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen S , ChenX , XieGet al. Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells . Oncotarget7 ( 26 ), 40362 – 40376 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Milhem M , MahmudN , LavelleDet al. Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A . Blood103 ( 11 ), 4102 – 4110 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Yang H , HoshinoK , Sanchez-GonzalezBet al. Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid . Leuk. Res.29 ( 7 ), 739 – 748 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kamoda Y , IzumiK , IiokaFet al. Philadelphia chromosome-positive acute lymphoblastic leukemia is separated into two subgroups associated with survival by BCR-ABL fluorescence in situ hybridization of segmented cell nuclei: report from a single institution . Acta Haematol.136 ( 3 ), 157 – 166 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Stresemann C , LykoF . Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine . Int. J. Cancer123 ( 1 ), 8 – 13 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Robert T , VanoliF , ChioloIet al. HDACs link the DNA damage response, processing of double-strand breaks and autophagy . Nature471 ( 7336 ), 74 – 79 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo O , LeeA , NussenzweigM , NussenzweigA . H2AX: the histone guardian of the genome . DNA Repair (Amst.)3 ( 8–9 ), 959 – 967 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Shao RG , CaoCX , PommierYet al. Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells . Acta Pharmacol. Sin.25 ( 6 ), 756 – 762 ( 2004 ).
   PubMed Web of Science ®Google Scholar